Devices › Assay, glycosylated hemoglobin
Device brand name · Hemoglobin a1c kit
Dimension R Clinical Chemistry System: medical device reports filed with FDA
399 reports name it, 2011–2016. Manufacturer given most often on reports: Siemens Healthcare Diagnostics - Glasgow. Product code LCP.
- 399
- device reports naming the brand
- 0% of all MAUDE reports · about 26 a year
- 0
- reports, 12 months to August 2026
- 0 in the 12 months before
- 99.5%
- classified as malfunction
- 96.7% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
FDA's MAUDE database holds 399 reports that name the brand "Dimension R Clinical Chemistry System" (hemoglobin a1c kit), received between January 2011 and August 2016; the manufacturer given most often on reports is Siemens Healthcare Diagnostics - Glasgow. Spellings of one product vary from report to report.
0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (99.5%) and injury (0.5%); across all assay, glycosylated hemoglobin reports (product code LCP) death is recorded in 0% and malfunction in 96.7%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are high test results (50.4%), nonstandard device (26.8%) and incorrect or inadequate test results (17.3%). The patient problems coded most often are overdose, encephalopathy and hemoptysis. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
No report naming Dimension R Clinical Chemistry System was received in the five years to August 2026; the latest was received in August 2016.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 2,951 reports carrying product code LCP. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| High test results | 201 | 50.4% | 14.2% |
| Nonstandard device | 107 | 26.8% | 5.9% |
| Incorrect or inadequate test results | 69 | 17.3% | 6.6% |
| Calibration problem | 61 | 15.3% | 0.9% |
| Incorrect, inadequate or imprecise result or readings | 24 | 6% | 8.4% |
| Low test results | 22 | 5.5% | 2.1% |
| False positive result | 17 | 4.3% | 0.3% |
| Device operates differently than expectedthe device behaved unexpectedly | 12 | 3% | 21.5% |
| Calibration error | 9 | 2.3% | 0.2% |
| Improper or incorrect procedure or method | 5 | 1.3% | 0.6% |
| False reading from device non-compliance | 4 | 1% | 0.1% |
| Human-device interface problem | 3 | 0.8% | 0.1% |
| Failure to calibrate | 2 | 0.5% | 0.3% |
| Structural problem | 2 | 0.5% | 0% |
| Device ingredient or reagent problem | 1 | 0.3% | 1.2% |
| False negative result | 1 | 0.3% | 0% |
| High readingsreadings were too high | 1 | 0.3% | 0.5% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Overdosea dose above the recommended amount | 2 | 0.5% |
| Encephalopathy | 1 | 0.3% |
| Hemoptysis | 1 | 0.3% |
| Missed dose | 1 | 0.3% |
| Renal failurekidney failure | 1 | 0.3% |
| Test result | 1 | 0.3% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Dimension R Clinical Chemistry System | Product code LCP | All MAUDE reports |
|---|---|---|---|
| Reports | 399 | 2,951 | 26,136,888 |
| Share of that pool | — | 13.5% | 0% |
| Classified as death, per 1,000 reports | 0 | 0 | 9 |
| Classified as injury | 0.5% | 0.9% | 36.2% |
| Classified as malfunction | 99.5% | 96.7% | 62.3% |
| Filed by the manufacturer | 100% | 97.9% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code LCP
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Tosoh Hlc-723g8 Analyzer G8 | 1,343 | 0 | 0% |
| Tosoh Hlc-723g8 Analyzer | 336 | 0 | 0% |
| Tosoh Hlc-723ga Analyzer G8 | 193 | 0 | 0% |
| Dimension Vista R Clinical Chemistry System | 208 | 0 | 0% |
| G7 | 236 | 82 | 0% |
| Aia-900 | 1,377 | 71 | 0% |
| Aia-360 | 1,034 | 42 | 0% |
| Aia-2000 | 969 | 57 | 0% |
| Dimension Clinical Chemistry System | 1,895 | 0 | 0.2% |
| Dimension Exl 200 | 487 | 0 | 0% |
| Dimension Xpand Plus With Hm | 215 | 0 | 0% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Dimension R Clinical Chemistry System reports
How many FDA reports name Dimension R Clinical Chemistry System?
399 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.
What kinds of events are reported?
malfunction (99.5%) and injury (0.5%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
high test results (50.4%), nonstandard device (26.8%), incorrect or inadequate test results (17.3%), calibration problem (15.3%) and incorrect, inadequate or imprecise result or readings (6%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Dimension R Clinical Chemistry System was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.